-+ 0.00%
-+ 0.00%
-+ 0.00%

CORCEPT THERAPEUTICS INC : UBS INITIATES COVERAGE WITH NEUTRAL RATING AND TARGET PRICE $95

Reuters·12/16/2025 14:46:29

Please log in to view news